ELP1 and Riley-Day syndrome: Similarly, a small molecule drug kinetin was able to reverse the mis-splicing of the IKBKAP gene in familial dysautonomia patient-derived ectomesenchymal cells (Boone et al., 2010) as it has in iPSCs from these patients (Lee et al., 2009).